Clinical implementation of preemptive pharmacogenomics in psychiatryResearch in context

Clinical implementation of preemptive pharmacogenomics in psychiatryResearch in context

Summary: Background: Pharmacogenomics (PGx) holds promise to revolutionize modern healthcare. Although there are several prospective clinical studies in oncology and cardiology, demonstrating a beneficial effect of PGx-guided treatment in reducing adverse drug reactions, there are very few such stu...

Full description

Bibliographic Details
Main Authors: Maria Skokou, Kariofyllis Karamperis, Margarita-Ioanna Koufaki, Evangelia-Eirini Tsermpini, Maria-Theodora Pandi, Stavroula Siamoglou, Panagiotis Ferentinos, Marina Bartsakoulia, Theodora Katsila, Christina Mitropoulou, George P. Patrinos, Konstantinos Assimakopoulos, Eleni Georgila, Philippos Gourzis, Aikaterini Karaivazoglou, Olympia Prodromaki, George Rigas, Georgia Voukelatou, Vassiliki Zacharopoulou, Evangelia Barba, Konstantina Chalikiopoulou, Dimitra Dedousi, Georgia Emmanouil, Panagiotis Giannopoulos, Ouliana Ivantsik, Marina Kalogeropoulou, Manoussos E. Kambouris, Filippos Kanellakis, Alexandra Kolliopoulou, Panagiotis Kollios, Zoi Kordou, Ioannis Liopetas, Efrossyni Mendrinou, Konstantinos Mitropoulos, Georgia-Chryssa Samiou, Theano Stamopoulou, Andreas Stathoulias, Apostolos Stratopoulos, Athina Tsikrika, Athanassios Douzenis, Charilaos Gerassimou, Maria-Angeliki Voziki, Athanassios Vozikis
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:EBioMedicine
Subjects:
Preemptive pharmacogenomics
Clinical implementation
Schizophrenia
Major depressive disorder
Bipolar disorder
Cost-effectiveness
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396424000446

Internet

http://www.sciencedirect.com/science/article/pii/S2352396424000446

Similar Items